期刊文献+

iNOS在口腔鳞状细胞癌中的表达及其预后意义

EXPRESSION OF INOS AND ITS PROGNOSTIC SIGNIFICANCE IN ORAL SQUAMOUS CELL CARCINOMA
下载PDF
导出
摘要 目的:调查诱导型一氧化氮合酶(iNOS)在口腔鳞状细胞癌(OSCC)中的表达及其预后意义。方法:48例OSCC经外科手术治疗后被分为两组:接受新辅助化疗24例及另外24例仅接受手术治疗。通过免疫组织化学方法评价了来自48例OSCC的经福尔马林固定、石蜡包埋预处理标本内的iNOS表达水平。结果:在48例OSCC中有47例被发现有iNOS染色,而在邻近正常口腔粘膜组织内却没有发现。在接受化疗者中,在高iNOS表达与颈部淋巴结转移之间存在一个显著性关系(P>0.05),而在仅接受手术治疗者中,低iNOS表达却与颈部淋巴结转移之间存在部分显著性关系。而且,高iNOS表达显著地与更高的生存率有关(P<0.01)。结论:iNOS过表达可能通过生成一氧化氮(NO)对肿瘤的发病起了重要作用。但是,在口腔癌中iNOS表达的临床意义仍然未明。为了全面建立起iNOS与肿瘤生物行为之间的关系,进一步的研究是必要的。 Objective:To investigate the expression of inducible nitric oxide synthase (iNOS) and its prognostic significance in oral squamous cell carcinoma (OSCC). Methods:48 cases OSCC underwent surgical operation and were classified into 2 groups : 24 cases with neoadjuvant chemotherapy and another 24 cases surgery alone. The level of iNOS expression was evaluated in formalin fixed paraffin embedded pretreatment specimens from 48 OSCCs by immunohistochemical method. Results:iNOS staining was detected in 47 of the 48 OSCCs but not in adjacent normal oral mucosal tissues. There was a significant correlation between high iNOS expression and cervical lymph node metas tasis in patients with chemotherapy ( P 〈 0.05), whereas low iNOS expression subsignificantly correlated with cervical lymph node metastasis in cases surgery alone. Moreover, high iNOS expression significantly correlated with higher survival rate(P 〈0.01 ). Conclusion: Overexpression of iNOS might make an important contribution to tumor formation through production of nitric oxide (NO). However, the clinical importance of the expression of. iNOS in oral cancer remains unclear. Further research is required to fully establish the relationship between iNOS and biological tumor behavior.
出处 《牡丹江医学院学报》 2007年第6期22-25,共4页 Journal of Mudanjiang Medical University
关键词 诱导型一氧化氮合酶 口腔鳞状细胞癌 免疫组织化学方法 肿瘤生物行为 iNOS OSCC immunohistochemical method biological tumor behavior
  • 相关文献

参考文献10

  • 1Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985[J]. Int J Cancer, 1993,54(4) : 594 - 606.
  • 2Moncada S, Palmer RM, Higgs E. Nitric oxide: physiology, pathophysiology and pharmacology[J]. Pharmacol Rev, 1991,43(2) :109 - 142.
  • 3Jenkin DC, Charles IG, Thomson LL, et al. Role of nitric oxide in tumor growth[J]. Proc Natl Acad Sci USA, 1995,92(10) :4392 - 4396.
  • 4Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: a review[J]. Mutat Res, 1995,339(2) :73 -89.
  • 5Beevi SS, Rasheed AM, Geetha A. Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer[ J]. Jpn J Clin Oncol, 2004 ,34 (7) :379 - 385.
  • 6Cook JA, Gius D, Mitchell JB, et al. Oxidative stress, redox, and the tumor microenvironment [ J ]. Semin Radiat Oncol, 2004,14 ( 3 ) : 259 - 266.
  • 7Wink DA, Mitchell JB. Nitric oxide and cancer: an introduction[ J]. Free Radic Biol Med, 2003,34(8) :951 -954.
  • 8Chen YK, Hsue SS, Lin LM. Increased expression of inducible nitric oxide synthase for human buccal squamous - cell carcinomas: immunohistechemical, reverse transcription - polymerase chain reaction (RT-PCR) and in sire RT-PCR studies[ J]. Head Neck, 2002, 24(10) :925 -932.
  • 9陈伟良,曾曙光,李海刚,黄洪章,潘朝斌.舌鳞癌组织iNOSmRNA表达及其意义[J].癌症,2002,21(3):314-318. 被引量:18
  • 10Harada K, Supriatno, Kawaguchi S, et al. Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells [J]. In Vivo, 2004,18(4) :449 -455.

二级参考文献9

  • 1Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer [J]. J Natl Cancer Inst, 1998,90(8):587-596.
  • 2Rosbe J, Kristina W, Petrusz P, et al. Immunohistochemical characterzation of nitric oxide synthase activity in squamous cell carcinoma of the head and neck [J]. Otolaryngology Head & Neck Surgery, 1995,113(5):541-549.
  • 3Thomsen LL, James MJ, Scott, et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo:studies with 1400W, a novel inhibitor [J]. Cancer Res, 1997,57:3300-3304.
  • 4Chin K, Kurashima Y, Ogura T, et al. Induction of Vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular Carcinoma Cells [J]. Oncogene,1997,15:437-442.
  • 5Meyer RE, Shan S, DeAngelo J, et al. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma [J]. Br J Cancer,1995,11:1169-1174.
  • 6Lejeune P, Lagadec P, Onier N, et al. Nitric oxide involvment in tumor-induced immunosuppression [J]. J Immunol, 1994,152:5077-5083.
  • 7Yagihashi N, Kasajima H, Sugai S, et al. Increased in situ expression of nitric oxide synthase in human coorectal cancer [J]. Virchows-Arch,2000,436(2):109-114.
  • 8Orucevic A,Bechberger J,Green AM,et al.Nitric-oxide production by murine mammary adenocarcinoma cell promotes tumor-cell invasiveness [J]. Int J Cancer, 1999,81:889-896.
  • 9陈伟良,李海刚,潘朝斌,黄洪章.一氧化氮合酶在舌鳞癌组织中的表达及其与预后的关系[J].中华口腔医学杂志,1998,33(3):152-154. 被引量:27

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部